COMMUNIQUÉS West-GlobeNewswire

Hemostemix Announces OTCQB Listing and DTC Eligibility
30/10/2018
CALGARY, Alberta, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce the Company has been approved for up-listing its common [...]
Predictive Technology Group Appoints Industry Veteran John E. Sorrentino as Chairman
30/10/2018
Sorrentino Expands Role to Support Goal of Bringing Innovative Technologies to Market SALT LAKE CITY , Oct. 30, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data [...]
Pure Pharmacy Group to Offer Molecular You’s Preventive Health Assessments across all Lower Mainland Locations
30/10/2018
Brings together conventional and preventive healthcare under one roof VANCOUVER, B.C., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Pure Integrative Pharmacy and Molecular You, the personalized health company, are joining forces [...]
NewLink Genetics to Participate in the Stifel 2018 Healthcare Conference
30/10/2018
AMES, Iowa, Oct. 30, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a clinical stage biopharmaceutical company focused on developing novel immuno-oncology therapeutic candidates, announced today it [...]
NSS Labs Announces Results of Second Edition of 2018 Data Center Intrusion Prevention System Group Test
30/10/2018
Three Products Receive Recommended Rating AUSTIN, Texas, Oct. 30, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based cybersecurity guidance, today announced the [...]
Progressive Care Enters into Definitive Agreements to Purchase Property for Third Pharmacy Location in South Florida
30/10/2018
MIAMI, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that through its [...]
Advantis Corp. Looking to Team Up For MJBIZCON
30/10/2018
NEWPORT BEACH, CA, Oct. 30, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it is in negotiations to partner with two undisclosed publicly traded companies to present at [...]
Abattis Bioceuticals Offers Comfort to Those Suffering with Chronic Pain & Inflammation -- CFN Media
30/10/2018
SEATTLE, Oct. 30, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
New Study Cites 82 Percent Mortality and 56 Percent Rehospitalization Reductions 30 Days After Therapy Guided by Daxor’s BVA-100 Blood Volume Analyzer in Acute Heart Failure Patients
30/10/2018
Controlled Study of BVA-100 Published in The Journal of the American College of Cardiology – Heart Failure Showed 86 Percent Reduction in One-Year Mortality NEW YORK , Oct. 30, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation [...]
International Stem Cell Corporation to Present Clinical Data at the Society for Neuroscience Annual Meeting
30/10/2018
CARLSBAD, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
Yield10 Bioscience to Host Webcast of its Third Quarter 2018 Conference Call
30/10/2018
WOBURN, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, announced [...]
Ultragenyx to Host Conference Call for Third Quarter 2018 Financial Results and Corporate Update
30/10/2018
NOVATO, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Bloomberg Interviews FSD Pharma for Cannabis Shortage Feature -- CFN Media
30/10/2018
SEATTLE, Oct. 30, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Biodesix Advances ORACLE Registry for Lung Nodule Cancer Test
30/10/2018
Noninvasive Test to Rule Out Cancer Expected to Lower Patient Anxiety and Costs BOULDER, Colo., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Biodesix ® today provided an update on the Observational Registry study to evaluate the [...]
RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST NINE MONTHS 2018. REVENUES +5.1%, EBITDA +11.1%, OPERATING INCOME +9.6%, NET INCOME +8.2%. INTERIM DIVIDEND € 0.45 (+7.1%)
30/10/2018
RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST NINE MONTHS 2018. REVENUES +5.1%, EBITDA +11.1%, OPERATING INCOME +9.6%, NET INCOME +8.2%. INTERIM DIVIDEND € 0.45 (+7.1%). Consolidated revenues € 1,013.3 [...]
The Foundation for Women’s Cancer and TESARO Partner on the Race to End Women’s Cancer for 3rd Year
30/10/2018
CHICAGO and WALTHAM, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- The Foundation for Women’s Cancer (FWC), the official foundation of the Society of Gynecologic Oncology (SGO), and TESARO, Inc. (NASDAQ:TSRO), an oncology- [...]
Leading BioSciences Announces Appointments of James R. Neal and James Sapirstein to Board of Directors
30/10/2018
Experienced Industry Executives Provide Company with Broad Life Science Industry Expertise Including Drug Development and Commercialization CARLSBAD, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug [...]
Iovance Biotherapeutics to Host Third Quarter 2018 Financial Results Conference Call and Webcast on Tuesday, November 6, 2018
30/10/2018
SAN CARLOS, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]
Immune Design to Report Third Quarter 2018 Financial Results and Provide Corporate Update
30/10/2018
SEATTLE and SOUTH SAN FRANCISCO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ), an immunotherapy company focused on next-generation therapies in oncology, today announced that it will report third [...]

Pages